The Mexico home diagnostic testing market was valued at USD 298.23 Million in 2025 and is expected to grow at a CAGR of 5.00%, reaching USD 485.79 Million by 2035. The market growth is driven by the rising prevalence of chronic diseases and growing health awareness among Mexico’s aging population. The market is also driven by the increasing demand for rapid and accurate home-based testing across the region.
Base Year
Historical Period
Forecast Period
Abbott’s Panbio™ HIV Self-Test launch in July 2024 is accelerating adoption of at-home diagnostic solutions across Mexico.
COFEPRIS’ Abbreviated Regulatory Pathway from September 2025 enables faster approvals, enhancing market entry for medical devices and diagnostics.
Rising consumer health awareness and preference for private, convenient testing are driving sustained growth in Mexico’s home diagnostic testing market.
Compound Annual Growth Rate
5%
Value in USD Million
2026-2035
*this image is indicative*
The market is witnessing steady growth driven by increased awareness of personal health and the need for early disease detection. Chronic illnesses, such as diabetes, hypertension, and obesity, are highly prevalent, motivating consumers to adopt self-testing kits. Technological improvements, including rapid and accurate point-of-care tests, support market expansion. Telemedicine adoption and government health initiatives also promote remote monitoring. Both local and international manufacturers are introducing innovative and user-friendly products to cater to the rising demand among urban and semi-urban populations. The market is anticipated to grow at a CAGR of 5.00% during the forecast period of 2026-2035.
Rising Adoption of At-Home HIV Diagnostic Testing in Mexico to Boost Market Growth
The launch of Abbott’s Panbio™ HIV Self-Test in Mexico in July 2024 is driving growth in the country’s market. Approved by COFEPRIS, this rapid, over-the-counter test allows individuals to detect HIV-1 and HIV-2 antibodies privately at home, delivering results within 15–20 minutes. Improving accessibility and reducing stigma associated with clinic-based testing encourages early diagnosis and timely treatment. This development reflects a broader trend toward self-administered diagnostics, boosting consumer confidence and expanding the home testing segment in Mexico.
Major market trends include regulatory ease and rising consumer demand.
Ease in Regulatory Approvals to Impact the Market Size Positively
Effective from September 1, 2025, Mexico's health authority COFEPRIS introduced an Abbreviated Regulatory Pathway, enabling medical device and drug manufacturers to expedite approvals by leveraging prior authorizations from trusted international regulators. This streamlined process promises 30-day evaluations, aligning Mexico more closely with global regulatory standards and offering manufacturers a faster route to market. Such initiatives are expected to boost the market value for diagnostic tests in the forecast period.
Increasing Adoption of Home Diagnostic Testing to Boost Mexico Home Diagnostic Testing Market Demand
The market is experiencing a growing demand for home diagnostic testing solutions. Factors contributing to this trend include increased health awareness, the convenience of at-home testing, and advancements in diagnostic technologies. Consumers are seeking accessible and private options to monitor their health, leading to a rise in the adoption of home testing kits for various conditions. This shift is influencing market dynamics and encouraging innovation in the home diagnostic testing sector.
Urine Sample to Lead the Market by Sample
The urine sample segment emerged as the dominant category, capturing the largest revenue share of more than 30% during the historical period. This preference is largely driven by the convenience, non-invasiveness, and reliability of urine-based tests, which allow users to monitor a wide range of health conditions from the comfort of their homes. Additionally, the growing awareness of preventive healthcare and increasing adoption of at-home diagnostics among Mexican consumers have further fueled the demand for urine sample testing, reinforcing its leading position in the market.
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Headquartered in Franklin Lakes, New Jersey, BD was founded in 1897. The company specializes in medical technology, offering a range of diagnostic solutions, including instruments and reagents for infectious disease and cancer detection. In 2025, BD announced plans to merge its Biosciences & Diagnostic Solutions division with Waters Corporation in a USD 17.5 billion deal, aiming to enhance its focus on medical technology.
Abbott Laboratories, established in 1888 and headquartered in Abbott Park, Illinois, is a global healthcare company. Its diagnostic portfolio includes point-of-care tests, glucose monitoring systems, and laboratory instruments. Abbott has been a pioneer in self-testing solutions, notably developing TestPack in 1986, a self-contained diagnostic test for blood-sophisticated immunoassay tests.
Founded in 1979 and headquartered in San Diego, California, QuidelOrtho Corporation is a leading provider of diagnostic healthcare products. The company specializes in immunoassay and molecular testing, with a strong presence in point-of-care settings and clinical labs. In 2021, Quidel acquired Ortho Clinical Diagnostics, expanding its diagnostic capabilities.
Roche, founded in 1896 and headquartered in Basel, Switzerland, is a global healthcare leader. Its diagnostics division offers a comprehensive range of tests, instruments, and digital solutions for disease prevention, diagnosis, and monitoring. Roche Diagnostics aims to transform healthcare by providing innovative diagnostic solutions worldwide.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other players in the market include Nova Biomedical, ACON Laboratories, Inc., OraSure Technologies, Inc., BTNX, Inc., ARKRAY Inc., and Siemens Healthcare GmbH.
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Test Type
Market Breakup by Product
Market Breakup by Sample
Market Breakup by Age Group
Market Breakup by Distribution Channel
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Test Type |
|
| Breakup by Product |
|
| Breakup by Sample |
|
| Breakup by Age Group |
|
| Breakup by Distribution Channel |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share